Africa Patient Safety Summit — Medicines for Africa
African healthcare leaders standing together
About the Summit

Advancing patient safety through collective action

Advancing patient safety through collective action to prevent medication-related harm.

Healthcare professionals collaborating on patient care
Why it exists

Closing the gap between perception and reality

Medication-related harm is one of the most preventable yet under-recognised causes of death in Africa. It costs lives and undermines economies.

It affects every part of the medicines ecosystem, and so, no single profession, institution or sector can solve it alone.

We need coordinated action. Without such action, the scale of preventable harm will continue to outpace our ability to prevent it.

Why this summit matters

A system-wide patient safety challenge

Medicines save lives every day across Africa. But because systems are failing, patients continue to be affected by:

Substandard and falsified medicines
Medication errors
Weak pharmacovigilance systems
Fragmented supply chains
Inadequate surveillance
Unsafe or irrational use of medicines

Our Vision

A coordinated African medicines ecosystem that delivers the safest possible use of medicines, free from preventable medication-related harm.

Our Mission

To build and sustain a continental platform that advances patient safety through patient-centred regulation, strengthened medicines safety systems, and collective action across the medicines ecosystem.

Our Objective

To convene key people and institutions across Africa's medicines ecosystem to align priorities, strengthen collaboration, and accelerate implementation of solutions that prevent medication-related harm.

Continental leadership in discussion
Continental leadership

A bridge between regulation and implementation

The Summit is hosted and convened by Medicines for Africa in partnership with the African Medicines Agency — creating a bridge between continental regulatory leadership and implementation across healthcare systems and industry.

Together, they are helping align continental regulatory leadership with implementation capacity, accelerating coordinated action for safer medicines and stronger patient protection across Africa.

What makes it different

Not a consultation. A platform for action.

This is not a WHO technical consultation, a global health summit, or a traditional regulatory conference. Three defining differences set it apart:

01

Implementation, not policy discussion

The objective is not to discuss the problem, but to coordinate action towards real-world impact.

02

Multi-actor design, not sector silos

Regulators, clinicians, industry, researchers, and communities design solutions together.

03

Actionable continental outputs, not recommendations

The Summit converts alignment into coordinated continental implementation.

What the Summit will achieve

From alignment to action

1

Prevent medication-related harm

By strengthening patient-centred regulation, pharmacovigilance and post-market surveillance, and medicines quality and safety systems.

2

Strengthen patient-centred regulation

Embedding patient safety, patient experience, and lived experience as core regulatory intelligence inputs — not peripheral feedback.

3

Drive coordinated ecosystem action

Building shared accountability across regulators, healthcare systems, industry, and communities — from fragmentation to execution alignment.

What the Summit will deliver

Continental outputs for implementation

  • Kigali Declaration on Patient Safety and Medication-Related Harm
  • Africa Medicines Safety Roadmap (Execution Framework)
  • Blueprint for Safer Medicines Use and Patient Protection
  • Continental Patient Safety Coordination Network
Patients and community members
Why it matters

Behind every regulation and every roadmap are patients and communities waiting for safer medicines.

Alignment only matters if it reaches them — that is the measure of success the Summit is built around.

Why now

Africa is at a critical inflection point

  • The African Medicines Agency is now established
  • Regulatory harmonisation is accelerating
  • Digital health systems are expanding rapidly
  • Investment in local manufacturing is growing
Who should attend

All stakeholders in the medicines ecosystem

Ministries of HealthAfrican Medicines Agency (AMA)National Regulatory AuthoritiesHealthcare Professionals and Clinical LeadersPharmaceutical and Life Sciences IndustryDigital Health InnovatorsResearchers and Academic InstitutionsDevelopment Partners and MultilateralsPatient Organisations and Civil Society